ReportsnReports: Partnering Agreements with Bigpharma

04-Mar-2012 | News-Press Release

The Partnering Agreements with Bigpharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharma companies.

Partnering Agreements with Bigpharma provides the user with the following key benefits:
• Detailed partnering activity profiles for each of the top 50 bigpharma companies
• Over 300 charts showing a company’s dealmaking activity since 2007, allowing quick identification potential partners
• Partnering therapy focus revealed
• Partnering activity since 2007 – number of deals per year
• Full listing of partnering deals
• Activity by deal type
• Activity by industry sector
• Activity by phase of development
• Activity by technology type
• Activity by therapeutic area
• Comprehensive access to over 3,000 partnering deals as recorded at Current Agreement, together with contract documents if available
• Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents
• Understand the key deal terms the company has agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Request a Sample for or Inquire before buying the report Bigpharma Partnering Agreements Report

Partnering Agreements with Bigpharma is intended to provide the reader with an in-depth understanding of the partnering activities of the leading fifty biopharma companies worldwide, enabling the effective assessment and selection of partners of choice, based on the latest knowledge of a company’s partnering.

Partnering Agreements with Bigpharma includes:
• Detailed company profiles for each of the top 50 bigpharma companies, including:
• Partnering interests and indications
• Partnering activity since 2007
• Partner companies since 2007
• Partnering activity since 2007 by:
• Partner company
• Deal type
• Industry sector
• Stage of development
• Technology type
• Therapy area
• Over 300 charts showing the dealmaking activity of each company since 2007
• The tools to enable effective and efficient preparation for partnering negotiation with bigpharma
• 3,000 partnering deals as recorded at Current Agreement, together with contract documents if available
• The leading M&A and partnering deals by value 2007-2012

Major points covered in Table of Contents of this report include:
• Executive Summary
• Chapter 1 – Introduction
• Chapter 2 – Bigpharma top 50 dealmaking activity
• Chapter 3 – Top bigpharma deals by value
• Chapter 4 – Submitting Opportunities to Bigpharma
• Chapter 5 – Forthcoming bigpharma partnering events
• Chapter 6 – Bigpharma Company Profiles
• Chapter 7 – Resources
• Appendices
• List of Figures

Explore Reports related to Biotechnology @

7557 Rambler road,
Tel: + 1 888 391 5441


Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Login to Submit Email

Author Info

Tag Cloud


More Releases


Add a Comment